Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Diffuse large B-cell lymphoma and rituximab: is bcl-2 the key?

Diffuse large B-cell lymphoma and rituximab: is bcl-2 the key?. Am J Onc Rev. 2003; 2:592-593.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.